Study: New DNA Vaccine Shuts Down Immune Cells that Cause Type 1 Diabetes
July 1, 2013 5:05 PM
comment(s) - last by
It leaves the rest of the immune system alone, though
Type 1 diabetes is a lifelong disease, but researchers at Stanford University are hoping to eliminate the effects of the disease -- and eventually cure it -- with a new vaccine.
Researchers from the Stanford School of Medicine -- led by Lawrence Steinman, MD, professor of pediatrics and of neurology and neurological sciences at Stanford -- have created a DNA vaccine that fights
type 1 diabetes
by targeting only a certain population of cells in the immune system without destroying the whole thing.
The vaccine consists of an altered piece of DNA, which holds the proinsulin gene. Beta cells, which are the only cells that make insulin in the body, start out as proinsulin precursor proteins. The beta cells, like all cells, display small pieces of the proteins they make on their surfaces called peptides, and the proinsulin peptides on the surface of beta cells cause misdirected CD8 cells (which are immune cells that patrol the cell surfaces for foreign peptides) to attack the beta cells.
The new DNA vaccine seeks out CD8 cells
targeting proinsulin; not all CD8 cells. If the vaccine had shut down the normal behavior of all CD8 cells, it would interfere with the patient's immune system and stop their bodies from being able to fight off infections and serious issues like cancer. Hence, shutting the whole system down isn't a better option.
That's why the vaccine only targets proinsulin-attacking CD8 cells and stops them from destroying beta cells while leaving everything else alone.
To test the vaccine, the research team recruited 80 type 1 diabetic patients that
required insulin therapy
. They divided the patients into five different groups, where four received different doses of the vaccine and one received a placebo.
Over the course of 12 weeks, the researchers measured levels of C-peptide in the patients, which is a piece of proinsulin that is cut off when insulin is pulled out of the proinsulin molecule. C-peptide is thought to fight off diabetic complications, such as eye and kidney damage.
The team checked the C-peptide levels before they began, then at five and 15 weeks, and then six, nine, 12, 18 and 24 months after starting on the vaccination. During these checks, blood was drawn 30, 60, 90 and 120 minutes after patients drank a modified milkshake.
According to results, levels of proinsulin-targeting CD8 cells were significantly depleted in patients who received the vaccine, compared with those getting placebo. However, other CD8 cells remained intact and left alone. Patients on the vaccine either had the same C-peptide levels or even increased levels, which would help them fight off diabetic complications later in life.
This article is over a month old, voting and posting comments is disabled
Not a cure....
7/2/2013 11:22:31 AM
I don't believe this is a "cure" in the traditional sense as in curing someone who already has the disease. A type I diabetic have lost all the beta cells which produce insulin as a result of the immune system attacking and killing the cells. I don't think this vaccine will result in the beta cells coming back/regenerating once they have been killed off.
What it can do, based on these initial studies, is block/prevent further deterioration/dead of beta cells in an individual in the early stages of the disease. This effectively will result in someone not becoming a type I diabetic by protecting the beta cells from being attacked by the immune system.
And if used as a general vaccine for the population (like the polio, chicken pox, MMR type vaccines) it could ultimately prevent formation of the disease in the population....thus curing/preventing the disease in the population.
"So if you want to save the planet, feel free to drive your Hummer. Just avoid the drive thru line at McDonalds." -- Michael Asher
Gene Therapy Controls, Cures Type 1 Diabetes in Dogs
February 11, 2013, 1:59 PM
Artificial Pancreas Improves Glucose Control by 15%, Benefits Type 1 Diabetes Patients
January 30, 2013, 5:55 PM
Crowdfunded Sex Toy Lets You Control the Action From Your Wii Nunchuk
January 15, 2015, 3:42 PM
Elon Musk Plays Warcraft; But Still Finds Time to Sleep, Build a Mars Colony Ship
January 6, 2015, 9:54 PM
SpaceX Scrubs Falcon 9 Launch to ISS, Barge Landing Test, Friday Redo Targeted
January 6, 2015, 4:02 PM
Quick Note; Wreckage of Malaysian-Owned Passenger Jet Found
December 30, 2014, 12:42 PM
Quick Note: Drone Loses Fight to the Death With Kangaroo
December 23, 2014, 3:28 PM
Campbell's Monkeys Found to Use Different Dialects to Describe Local Threats
December 22, 2014, 3:52 PM
Most Popular Articles
Microsoft Shows Off Latest Windows 10 Build, Preps it for Next Week Release
January 21, 2015, 2:57 PM
IDC: 2014 Sales Show PC Isn't Dead, But Desktop May be Dying
January 19, 2015, 1:50 PM
Police are Using New Handheld Radar Sensors to Peer Into Houses w/out Warrant
January 20, 2015, 1:35 PM
Great Expectations: The Rise and Fall of Google Glass Explorer Edition
January 16, 2015, 1:14 AM
Report: HTC One M9 (2015) is Tied to Under Armour-Powered HTC Smartwatch
January 19, 2015, 11:10 AM
Latest Blog Posts
Sceptre Airs 27", 120 Hz. 1080p Monitor/HDTV w/ 5 ms Response Time for $220
Dec 3, 2014, 10:32 PM
Costco Gives Employees Thanksgiving Off; Wal-Mart Leads "Black Thursday" Charge
Oct 29, 2014, 9:57 PM
"Bear Selfies" Fad Could Turn Deadly, Warn Nevada Wildlife Officials
Oct 28, 2014, 12:00 PM
The Surface Mini That Was Never Released Gets "Hands On" Treatment
Sep 26, 2014, 8:22 AM
ISIS Imposes Ban on Teaching Evolution in Iraq
Sep 17, 2014, 5:22 PM
More Blog Posts
Copyright 2015 DailyTech LLC. -
Terms, Conditions & Privacy Information